Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease

被引:18
|
作者
Mendoza, Yuly [1 ]
Cocciolillo, Sila [2 ]
Chen, Tianyan [1 ]
Margini, Cristina [2 ]
Sebastiani, Giada [1 ]
Berzigotti, Annalisa [2 ]
Murgia, Giuseppe [1 ]
机构
[1] Univ Bern, Bern Univ Hosp, Inselspital, Univ Clin Visceral Surg & Med,Dept Biomed Res, Bern, Switzerland
[2] McGill Univ, Royal Victoria Hosp, Div Gastroenterol & Hepatol, Hlth Ctr, Montreal, PQ, Canada
关键词
Cirrhosis; Ultrasound; NASH; Fibrosis; CONTROLLED ATTENUATION PARAMETER; STIFFNESS MEASUREMENT; RISK; COMPLICATIONS; PREDICTION; FIBROSIS;
D O I
10.1016/j.cgh.2020.04.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Some patients with compensated advanced chronic liver disease (cACLD) require use of an extralarge probe for liver stiffness measurement (LSM), owing to overweight or obesity. However, the ability of noninvasive markers of portal hypertension and the controlled attenuation parameter (CAP) to determine which of these patients are at risk for decompensation has not been fully assessed. METHODS: We collected data from 272 patients with cACLD (LSM double dagger 10 kPa by XL probe; 57% with nonalcoholic steatohepatitis; mean body mass index, 33.8 6.5 kg/m2; median Child-Pugh score, 5; median LSM, 16.8 kPa; mean CAP, 318 66 dB/m) evaluated at 2 academic centers from 2015 through 2018. We collected clinical data on decompensation (ascites, portal hypertension bleeding, jaundice, hepatic encephalopathy) and severe bacterial infections; patients were followed up for a median of 17 months (interquartile range, 11-24 mo). We evaluated associations between these events and LSM, CAP, LSM*spleen size/platelet count (LSPS), and portal hypertension risk scores. RESULTS: Decompensation occurred in 12 patients and severe bacterial infections developed in 5 patients. LSM, LSPS, and the portal hypertension risk score identified patients with decompensation with area under the receiver operating characteristic curve values of 0.848 (95% CI, 0.720-0.976; P < .0001), 0.881 (95% CI, 0.798-0.954; P < .0001), and 0.890 (95% CI, 0.814-0.966; P < .0001), respectively. In multivariate Cox regression analysis, in patients with nonalcoholic steatohepatitis, LSM and CAP were associated independently with decompensation and severe bacterial infection; CAP >= 220 dB/m was associated with a reduced risk of decompensation (hazard ratio, 0.043, 95% CI, 0.004-0.476; P =.01). CONCLUSIONS: LSM, LSPS, and the portal hypertension risk score identify obese or overweight patients with cACLD who are at increased risk of decompensation and severe bacterial infection.
引用
收藏
页码:3017 / +
页数:15
相关论文
共 50 条
  • [41] Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors
    Llop, Elba
    Berzigotti, Annalisa
    Reig, Maria
    Erice, Eva
    Reverter, Enric
    Seijo, Susana
    Abraldes, Juan G.
    Bruix, Jordi
    Bosch, Jaime
    Carlos Garcia-Pagan, Juan
    JOURNAL OF HEPATOLOGY, 2012, 56 (01) : 103 - 108
  • [42] Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria
    Elhence, Anshuman
    Anand, Abhinav
    Biswas, Sagnik
    Vaishnav, Manas
    Yadav, Rajni
    Das, Prasenjit
    Panwar, Rajesh
    Agarwal, Sandeep
    Gamanagatti, Shivanand
    Kumar, Ramesh
    Shalimar
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (03) : 1016 - 1025
  • [43] Diagnosis of esophageal varices by liver stiffness and serum biomarkers in virus-related compensated advanced chronic liver disease
    Zoughlami, Amine
    Serero, Jordana
    Congly, Stephen
    Zhao, Irene
    Zhu, Julie
    Ramji, Alnoor
    Cooper, Curtis
    Wong, Philip
    Bailey, Robert
    Coffin, Carla S.
    Sebastiani, Giada
    CANADIAN LIVER JOURNAL, 2023, 6 (03): : 332 - 346
  • [44] Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease
    Margini, Cristina
    Murgia, Giuseppe
    Stirnimann, Guido
    De Gottardi, Andrea
    Semmo, Nasser
    Casu, Stefania
    Bosch, Jaime
    Dufour, Jean-Francois
    Berzigotti, Annalisa
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (08) : 933 - 944
  • [45] A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease
    Kotwal, Vikram
    Mbachi, Chimezie
    Wang, Yuchen
    Attar, Bashar
    Randhawa, Tejinder
    Flores, Estefania
    Robles, Julian
    Rosenstengle, Craig
    Demetria, Melchor
    Adeyemi, Oluwatoyin
    Huhn, Gregory
    Murali, Arvind R.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (06) : 2084 - 2091
  • [46] Indocyanine Green Retention Test as a Noninvasive Marker of Portal Hypertension and Esophageal Varices in Compensated Liver Cirrhosis
    Lisotti, Andrea
    Azzaroli, Francesco
    Buonfiglioli, Federica
    Montagnani, Marco
    Cecinato, Paolo
    Turco, Laura
    Calvanese, Claudio
    Simoni, Patrizia
    Guardigli, Massimo
    Arena, Rosario
    Cucchetti, Alessandro
    Colecchia, Antonio
    Festi, Davide
    Golfieri, Rita
    Mazzella, Giuseppe
    HEPATOLOGY, 2014, 59 (02) : 643 - 650
  • [47] A Combined Model of Spleen Stiffness and Baveno VII Criteria for Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease: An International Multicenter Study
    Liu, Chuan
    Li, Jie
    He, Ruiling
    Grgurevic, Ivica
    Guo, Ying
    Liu, Shirong
    Hirooka, Masashi
    Wong, Yu Jun
    Yang, Ling
    Jaman, Mislav Barisic
    Madir, Anita
    Koizumi, Yohei
    Hiasa, Yoichi
    Liu, Jiacheng
    Guo, Xiaoqing
    Gao, Bo
    Liu, Ning
    Liu, Shanghao
    Ma, Jianzhong
    Zhang, Liting
    Ravaioli, Federico
    Colecchia, Antonio
    Qi, Xiaolong
    PORTAL HYPERTENSION & CIRRHOSIS, 2025, : 4 - 12
  • [48] Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease
    Pons, Monica
    Simon-Talero, Macarena
    Millan, Laura
    Ventura-Cots, Meritxell
    Santos, Begona
    Augustin, Salvador
    Genesca, Joan
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (10) : 1214 - 1219
  • [49] Compensated Advanced Chronic Liver Disease and Steatosis in Patients with Type 2 Diabetes as Assessed through Shear Wave Measurements and Attenuation Measurements
    Barisic-Jaman, Mislav
    Milosevic, Marko
    Skurla, Viktoria
    Dohoczky, David
    Stojic, Josip
    Kujundzic, Petra Dinjar
    Berkovic, Maja Cigrovski
    Majic-Tengg, Ana
    Matijaca, Ana
    Lucijanic, Tomo
    Kardum-Pejic, Mirjana
    Jaksic, Vlatka Pandzic
    Marusic, Srecko
    Grgurevic, Ivica
    BIOMEDICINES, 2024, 12 (02)
  • [50] Risk stratification of decompensation using liver stiffness and platelet counts in compensated advanced chronic liver disease (CHESS2102)
    Liu, Yanna
    Liu, Chuan
    Li, Jia
    Kim, Tae Hyung
    Enomoto, Hirayuki
    Qi, Xiaolong
    JOURNAL OF HEPATOLOGY, 2022, 76 (01) : 248 - 250